Cargando…
The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study
BACKGROUND: Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have superior survival when treated in pediatric versus adult centers (locus of care; LOC). Several adult centers recently adopted pediatric protocols. Whether this has narrowed LO...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536996/ https://www.ncbi.nlm.nih.gov/pubmed/30912628 http://dx.doi.org/10.1002/cam4.2096 |
_version_ | 1783421902585331712 |
---|---|
author | Gupta, Sumit Pole, Jason D. Baxter, Nancy N. Sutradhar, Rinku Lau, Cindy Nagamuthu, Chenthila Nathan, Paul C. |
author_facet | Gupta, Sumit Pole, Jason D. Baxter, Nancy N. Sutradhar, Rinku Lau, Cindy Nagamuthu, Chenthila Nathan, Paul C. |
author_sort | Gupta, Sumit |
collection | PubMed |
description | BACKGROUND: Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have superior survival when treated in pediatric versus adult centers (locus of care; LOC). Several adult centers recently adopted pediatric protocols. Whether this has narrowed LOC disparities in real–world settings is unknown. METHODS: The IMPACT Cohort is an Ontario population–based cohort that captured demographic, disease and treatment (treatment protocol, chemotherapy doses) data for all 15‐21 year olds diagnosed with ALL 1992‐2011. Cancer outcomes were determined by chart abstraction and linkage to provincial healthcare databases. Treatment protocols were classified as pediatric‐ or adult‐based. We examined predictors of outcome, including LOC, protocol, disease biology, and time period. RESULTS: Of 271 patients, 152 (56%) received therapy at adult centers. 5‐year event‐free survival (EFS ± SE) among AYA at pediatric vs adult centers was 72% ± 4% vs 56% ± 4% (P = 0.03); 5‐year overall survival (OS) was 82% ± 4% vs 64% ± 4% (P < 0.001). After adjustment, OS remained inferior at adult centers (hazard ratio 2.5; 95% confidence interval 1.1‐6.1; P = 0.04). In the most recent period (2006‐2011), 39/59 (66%) AYA treated at adult centers received pediatric protocols. These AYA had outcomes superior to the 20 AYA treated on adult protocols, but inferior to the 44 AYA treated at pediatric centers (EFS 72% ± 5% vs 60% ± 9% vs 81% ± 6%; P = 0.02; OS 77% ± 7% vs 65% ± 11% vs 91% ± 4%; P = 0.004). Induction deaths and treatment–related mortality did not vary by LOC. CONCLUSIONS: Survival disparities between AYA with ALL treated in pediatric vs adult centers have persisted over time, partially attributable to incomplete adoption of pediatric protocols by adult centers. Although pediatric protocol use has improved survival, residual disparities remain, perhaps due to other differences in care between adult and pediatric centers. |
format | Online Article Text |
id | pubmed-6536996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65369962019-06-03 The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study Gupta, Sumit Pole, Jason D. Baxter, Nancy N. Sutradhar, Rinku Lau, Cindy Nagamuthu, Chenthila Nathan, Paul C. Cancer Med Clinical Cancer Research BACKGROUND: Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have superior survival when treated in pediatric versus adult centers (locus of care; LOC). Several adult centers recently adopted pediatric protocols. Whether this has narrowed LOC disparities in real–world settings is unknown. METHODS: The IMPACT Cohort is an Ontario population–based cohort that captured demographic, disease and treatment (treatment protocol, chemotherapy doses) data for all 15‐21 year olds diagnosed with ALL 1992‐2011. Cancer outcomes were determined by chart abstraction and linkage to provincial healthcare databases. Treatment protocols were classified as pediatric‐ or adult‐based. We examined predictors of outcome, including LOC, protocol, disease biology, and time period. RESULTS: Of 271 patients, 152 (56%) received therapy at adult centers. 5‐year event‐free survival (EFS ± SE) among AYA at pediatric vs adult centers was 72% ± 4% vs 56% ± 4% (P = 0.03); 5‐year overall survival (OS) was 82% ± 4% vs 64% ± 4% (P < 0.001). After adjustment, OS remained inferior at adult centers (hazard ratio 2.5; 95% confidence interval 1.1‐6.1; P = 0.04). In the most recent period (2006‐2011), 39/59 (66%) AYA treated at adult centers received pediatric protocols. These AYA had outcomes superior to the 20 AYA treated on adult protocols, but inferior to the 44 AYA treated at pediatric centers (EFS 72% ± 5% vs 60% ± 9% vs 81% ± 6%; P = 0.02; OS 77% ± 7% vs 65% ± 11% vs 91% ± 4%; P = 0.004). Induction deaths and treatment–related mortality did not vary by LOC. CONCLUSIONS: Survival disparities between AYA with ALL treated in pediatric vs adult centers have persisted over time, partially attributable to incomplete adoption of pediatric protocols by adult centers. Although pediatric protocol use has improved survival, residual disparities remain, perhaps due to other differences in care between adult and pediatric centers. John Wiley and Sons Inc. 2019-03-26 /pmc/articles/PMC6536996/ /pubmed/30912628 http://dx.doi.org/10.1002/cam4.2096 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Gupta, Sumit Pole, Jason D. Baxter, Nancy N. Sutradhar, Rinku Lau, Cindy Nagamuthu, Chenthila Nathan, Paul C. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study |
title | The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study |
title_full | The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study |
title_fullStr | The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study |
title_full_unstemmed | The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study |
title_short | The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study |
title_sort | effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: an impact cohort study |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536996/ https://www.ncbi.nlm.nih.gov/pubmed/30912628 http://dx.doi.org/10.1002/cam4.2096 |
work_keys_str_mv | AT guptasumit theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT polejasond theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT baxternancyn theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT sutradharrinku theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT laucindy theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT nagamuthuchenthila theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT nathanpaulc theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT guptasumit effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT polejasond effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT baxternancyn effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT sutradharrinku effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT laucindy effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT nagamuthuchenthila effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy AT nathanpaulc effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy |